Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 181 - 190 of 222 for bay. (0.07 seconds)

Qiming Venture Partners announced a 250 million RMB...
China life science IPOs raised $5.4 billion in the last...
Bayer Schering Pharma has launched...
Shanghai Pharmaceuticals will raise 8 billion RMB ($1.2...
Bayer Schering announced the China...
CCB’s $400 million China health care fund may...
Bayer Schering Pharma (XETRA: SCH)...
“In 2010, venture capital investment in China life...
Bayer Healthcare has announced it plans...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital